Vasco Azevedo | Molecular Genetics | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Vasco Azevedo
Universidade Federal de Minas Gerais
Vasco Azevedo
Affiliation Universidade Federal de Minas Gerais
Country Brazil
Scopus ID 57215010765
Documents 788
Citations 22,530
h-index 65
Subject Area Molecular Genetics
Event Global Academic Awards
ORCID 0000-0002-4775-2280

Vasco Azevedo, affiliated with Universidade Federal de Minas Gerais, has developed a distinguished academic profile in molecular genetics through extensive research output, scientific collaboration, and contributions to genomic sciences and biotechnology. His publication record, citation impact, and academic influence position him among researchers whose work has contributed significantly to contemporary molecular genetics research.[1]

Abstract

This article presents an academic overview of Vasco Azevedo and evaluates his suitability for recognition through the Best Researcher Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and contributions to molecular genetics. His academic record demonstrates long-term engagement in genomic research, microbial genetics, biotechnology, and collaborative scientific advancement, reflecting characteristics commonly associated with distinguished research excellence.[1][2]

Keywords

Best Researcher Award, Vasco Azevedo, Molecular Genetics, Genomics, Biotechnology, Scientific Impact, Research Excellence, Citation Analysis, Academic Achievement, Genomic Research

Introduction

Recognition through academic awards serves an important role in highlighting researchers whose scholarly activities have significantly influenced scientific understanding and innovation. Within molecular genetics, impactful research frequently involves genomic characterization, molecular mechanisms of biological systems, and translational applications that contribute to health, agriculture, and biotechnology. Vasco Azevedo’s academic portfolio demonstrates sustained engagement with these objectives and reflects a research trajectory marked by productivity, collaboration, and scientific influence.[1][3]

Research Profile

Vasco Azevedo is affiliated with Universidade Federal de Minas Gerais in Brazil and has established an extensive research record within molecular genetics and related disciplines. According to Scopus-author metrics, his scholarly profile includes hundreds of indexed documents, substantial citation accumulation, and a high h-index, reflecting sustained influence across multiple areas of genetic and genomic investigation.[1]

  • Primary research focus in molecular genetics and genomics.
  • Extensive publication portfolio in peer-reviewed scientific journals.
  • Participation in interdisciplinary and international collaborations.
  • Contribution to microbial genomics and biotechnology research.
  • Strong citation performance demonstrating scholarly influence.

Research Contributions

Azevedo’s research contributions encompass genomic sequencing, comparative genomics, molecular characterization of microorganisms, and bioinformatics-supported investigations. His work has supported deeper understanding of microbial diversity, genetic regulation, and biological systems relevant to biotechnology and health sciences. Through collaborative projects, his studies have contributed to the generation of genomic resources and scientific knowledge utilized by researchers worldwide.[2][4]

  • Advancement of microbial genomics research.
  • Development of genomic datasets and analytical resources.
  • Contributions to biotechnology-oriented genetic studies.
  • Support for interdisciplinary scientific collaboration.
  • Promotion of genomic applications in biological research.

Publications

The publication portfolio associated with Vasco Azevedo demonstrates long-term scholarly productivity across multiple subfields of molecular genetics. Research outputs include original articles, collaborative genomic studies, reviews, and methodological contributions that have received substantial scholarly attention. Representative publications are associated with internationally recognized journals and include works involving genome sequencing and molecular characterization.[4][5]

  • Peer-reviewed molecular genetics publications.
  • Collaborative genomic sequencing projects.
  • Bioinformatics and systems biology studies.
  • Research articles with high citation visibility.

Research Impact

Research impact can be evaluated through citation indicators, scholarly adoption, and influence on future investigations. With more than twenty-two thousand citations and a substantial h-index, Azevedo’s body of work demonstrates broad visibility within the scientific community. These metrics suggest that his publications continue to inform ongoing studies, contribute to scientific discourse, and support advancements in molecular genetics and genomics.[1][3]

Award Suitability

The Best Researcher Award typically recognizes originality, productivity, scientific influence, and contributions to the advancement of knowledge. Based on available academic indicators, Vasco Azevedo demonstrates several attributes commonly associated with award recipients, including sustained publication activity, substantial citation impact, leadership in molecular genetics research, and participation in collaborative scientific initiatives. His scholarly record reflects a commitment to research excellence and the generation of knowledge with enduring academic value.[1][2]

Conclusion

Vasco Azevedo’s academic profile illustrates a distinguished career characterized by extensive research output, significant citation impact, and meaningful contributions to molecular genetics. His achievements align closely with the objectives of the Best Researcher Award, which seeks to acknowledge individuals whose scholarly work advances scientific understanding and supports innovation. The available evidence suggests a strong record of research excellence, academic influence, and sustained contribution to the global scientific community.[1]

References

  1. Scopus author details: Vasco Azevedo, Author ID 57215010765. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57215010765
  2. Genomic characterization of multidrug-resistant Klebsiella pneumoniae from an outbreak in Northeastern Brazil: mechanisms of virulence and resistance. https://link.springer.com/article/10.1007/s42770-026-01882-3
  3. Sensitivity profile of tolerant and persistent Staphylococcus spp. from goat mastitis to Jatobá (Hymenaea martiana Hayne) extract. https://link.springer.com/article/10.1007/s42770-025-01828-1
  4. Bacterial cell envelope components of gut commensals: effects in host-microbe interaction. https://www.tandfonline.com/doi/full/10.1080/07853890.2026.2618429
  5. Streptococcus didelphis infection in free-ranging white-eared opossum (Didelphis albiventris) and Brazilian common opossum (Didelphis aurita): pathology, microbiologic, and genomic characterization. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0348357

Hadi Maleki-Kakelar | Molecular Biology | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Hadi Maleki-Kakelar | Molecular Biology | Best Researcher Award

Solid Tumor Research Center | Iran

Assist. Prof. Dr. Hadi Maleki-Kakelar is a prominent researcher recognized for his contributions to molecular targeted therapy, cancer nanomedicine, and drug delivery systems. His interdisciplinary work bridges molecular biology, microbiology, and nanotechnology to develop innovative solutions for cancer and infectious diseases. With 335 citations, 16 publications, and an h-index of 10, Assist. Prof. Dr. Hadi Maleki-Kakelar has demonstrated exceptional research impact. His publications in leading journals such as The Lancet, Gastric Cancer, Biotechnology Advances, and Life Sciences highlight breakthroughs in Helicobacter pylori carcinogenesis, probiotic-driven cancer therapy, and bioengineered microalgae for therapeutic protein production. His recent collaborations on macrophage-based regenerative therapeutics, engineered exosomes, and extracellular vesicle applications underscore his forward-thinking approach to translational and regenerative medicine. Actively involved in workshops on PCR, CRISPR, and bioinformatics,

Profile: Scopus | Orcid | Google Scholar

Featured Publications

  • Maleki-Kakelar, H., Barzegari, A., Dehghani, J., Hanifian, S., Saeedi, N., & Barar, J. (2019). Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer, 22(1), 23–36.

  • Dehghani, J., Adibkia, K., Movafeghi, A., Barzegari, A., Pourseif, M. M., & Maleki-Kakelar, H. (2018). Stable transformation of Spirulina (Arthrospira) platensis: A promising microalga for production of edible vaccines. Applied Microbiology and Biotechnology, 1–12.

  • Maleki-Kakelar, H., Dehnad, A., Hanifian, S., & Khani, S. (2013). Isolation and molecular identification of Streptomyces spp. with antibacterial activity from northwest of Iran. BioImpacts: BI, 3(3), 129.

  • Dehghani, J., Adibkia, K., Movafeghi, A., Maleki-Kakelar, H., Saeedi, N., & Barzegari, A. (2020). Towards a new avenue for producing therapeutic proteins: Microalgae as a tempting green biofactory. Biotechnology Advances, 40, 107499.

  • Maleki-Kakelar, H., Barzegari, A., Hanifian, S., Barar, J., & Omidi, Y. (2019). Isolation and molecular identification of Lactobacillus with probiotic potential from abomasums driven rennet. Food Chemistry, 272, 709–714.

İlhan Sabancılar | Molecular Oncology | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. İlhan Sabancılar | Molecular Oncology | Best Researcher Award

Bitlis Eren University | Turkey

Assist. Prof. Dr. İlhan Sabancılar is a biochemist and medical researcher at Bitlis Eren University, Turkey, whose work bridges biochemistry, molecular medicine, and pharmaceutical sciences. His research primarily focuses on the anticancer, antioxidant, antimicrobial, and anti-inflammatory properties of bioactive compounds, natural extracts, and nanomaterials. Assist. Prof. Dr. İlhan Sabancılar has contributed to the synthesis and biological evaluation of novel heterocyclic and aza-acyclic nucleoside derivatives, investigating their potential as therapeutic agents through molecular docking and cytotoxicity studies. His publications in journals such as Pharmaceuticals, Current Issues in Molecular Biology, and Reviews on Environmental Health reflect his expertise in oxidative stress, trace element biochemistry, and drug development. With 9 publications and 247 citations, he has established a growing scientific presence supported by multiple research projects on oxidative stress, viral inhibition, and cancer therapeutics. A member of the Turkish Biochemical Society and the Molecular Cancer Research Association, Assist. Prof. Dr. İlhan Sabancılar’s multidisciplinary approach and consistent research output position him as a promising scholar contributing significantly to the advancement of biomedical and biochemical sciences.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

1. Unsal, V., Cicek, M., & Sabancilar, İ. (2021). Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Reviews on Environmental Health, 36(2), 279–295.

2. Bilden, A., Sabancılar, İ., Yalçın Azarkan, S., Karadağlı, K., Kaya, S., Kahraman, M., & Çiçek, M. (2025). Investigating the therapeutic potential of crude leech saliva based on its anticancer, antioxidant, and anti-inflammatory effects. Current Issues in Molecular Biology, 47(5), 328.

3. Sabancilar, İ., Unsal, V., Demir, F., Toprak, G., & Pekkolay, Z. (2023). Does oxidative status affect serum sclerostin levels in patients with type 2 diabetes mellitus? Folia Medica, 65(1), 46–52.

4. Alhilal, M., Alhilal, S., Gomha, S. M., Farag, B., Sabancilar, İ., & Ouf, S. A. (2025). Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents. BMC Chemistry, 19(1), 255.

5. Muhammed Ayral, H. T., Toprak, S. F., Dedeoğlu, S., & Sabancılar, İ. (2021). Kronik Otitis Media’da Tiyol-Disülfid Homeostazının Değişikliği. Dicle Tıp Dergisi, 48(1), 197–204.

6. Toprak, G., Sabancılar, İ., Özcan, N., & Alkan, H. (2020). Total oxidant status (TOS), total antioxidant status (TAS), ferritin and vitamin D levels in patients with chronic hepatitis C. Microbiology and Infectious Diseases, 4(2), 1–4.

 

Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Published on by Global Academic Awards

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. 🦠🔬📚

Publication Profile

Scopus

Orcid

🎓 Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. 🧬🔬📖

🏅 Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. 🧪🔬📚

🔬 Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance 💊, and host-pathogen interactions 🏥. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. 🌍🔍

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan 🦠💊 (Heliyon, 2025) 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025) 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🤰🦠 (Pathogens, 2025) 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases 💊🦠 (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠🧪 (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan 💊🦠 (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024) 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review 🦠📖 (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients 💉🦠 (Human Vaccines and Immunotherapeutics, 2024) 
🔟 Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives 🦠💉 (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.

Genetics and Molecular Biology

Published on by Global Academic Awards

Introduction of Genetics and Molecular Biology

Genetics and Molecular Biology are at the forefront of understanding the intricate machinery that governs life itself. This dynamic field investigates the genetic material and molecular processes underlying inheritance, development, evolution, and the molecular mechanisms of diseases. It is a cornerstone of modern biological research and holds the promise of unlocking the secrets of life’s blueprint.

Genome Sequencing and Analysis:

The study of entire genomes, from humans to microbes, has revolutionized our understanding of genetics. Researchers in this subfield explore the structure and function of genes, regulatory elements, and the role of non-coding DNA.

Genetic Variation and Population Genetics:

Investigating how genetic variations occur within populations and evolve over time is essential for understanding the diversity of life. This subtopic delves into the mechanisms of genetic diversity, adaptation, and speciation.

Epigenetics:

Epigenetics explores changes in gene expression that do not involve alterations to the DNA sequence itself. Researchers study how factors like DNA methylation and histone modification influence gene regulation, development, and disease.

Molecular Mechanisms of Disease:

In this subfield, scientists investigate the molecular basis of genetic disorders and diseases, from cancer to rare genetic conditions. Understanding the underlying mechanisms is crucial for developing targeted therapies.

Synthetic Biology:

Synthetic biology involves the design and construction of artificial biological systems for diverse applications, such as biofuel production or medical treatments. Researchers engineer biological components to create new functions and capabilities.

[post_grid id=”12288″]